Modified doxorubicin for improved encapsulation in PVA polymeric micelles

Area of Science:

• Polymer Chemistry
• Drug Delivery Systems
• Nanotechnology

Background:

• Polymeric micelles offer a promising platform for encapsulating hydrophobic drugs.
• Developing efficient drug encapsulation and targeted delivery remains a challenge.

Purpose of the Study:

• To synthesize and characterize novel polyvinylalcohol-based polymeric micelles for lipophilic drug delivery.
• To investigate the effect of polymer-drug chain similarity on encapsulation efficiency.
• To evaluate the potential of these micelles for targeted drug delivery to solid tumors.

Main Methods:

• Synthesis of polyvinylalcohol partially substituted with oleoyl or linoleoyl chains.
• Formation and characterization of polymeric micelles using dynamic light scattering.
• Hydrophobization of doxorubicin with an oleoyl chain for enhanced encapsulation.
• In vitro stability studies in phosphate buffer saline and drug release assays using pronase-E.

Main Results:

• Polymeric micelles were successfully formed with sizes dependent on polymer concentration.
• Enhanced doxorubicin encapsulation was observed when its lipophilic chain (oleoyl) matched the polymer's pendant groups.
• Drug release was triggered by pronase-E, indicating enzyme-sensitive payload delivery.
• The micelle size was found to be compatible with tumor vasculature.

Conclusions:

• Polyvinylalcohol-based polymeric micelles demonstrate effective encapsulation of lipophilic drugs.
• Tailoring polymer and drug hydrophobicity is crucial for optimizing encapsulation.
• Enzyme-activated drug release from these micelles holds potential for targeted cancer therapy.